TGF-β signaling in health, disease and therapeutics

Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?

The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosis

JAK‐2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis